BioMarin Pharmaceutical Inc. buy Guggenheim
Start price
13.09.23
/
50%
€85.26
Target price
13.09.24
€102.48
Performance (%)
-11.56%
End price
14.09.24
€75.40
Summary
This prediction ended on 14.09.24 with a price of €75.40. The price of BioMarin Pharmaceutical Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -11.56%. Guggenheim has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
BioMarin Pharmaceutical Inc. | -1.844% | -1.844% | -24.622% |
iShares Core DAX® | 1.518% | 3.456% | 25.970% |
iShares Nasdaq 100 | 1.240% | 2.983% | 31.325% |
iShares Nikkei 225® | 2.808% | 2.743% | 19.597% |
iShares S&P 500 | 0.403% | 2.187% | 28.624% |
Comments by Guggenheim for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $110.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Guggenheim for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€94.17
28.02.23
28.02.23
€117.80
28.02.24
28.02.24
-13.41%
29.02.24
29.02.24